Clinical Infectious Diseases · 2010 · 64 citations · 8 references
PharmacyPediatricsPharmacotherapyPediatric Clinical PharmacologyPediatric Infectious DiseasesPediatric PharmacotherapyAntiviral Drug ResistanceAntiviral PharmacologyAntiviral PharmacotherapyAntiviral ResistanceAntiviral TherapyPneumonia PharmacotherapyAntimicrobial Resistance In ChildrenImmunosuppressed Patient ManagementInfluenza Antiviral ResistanceInfluenza Antiviral TherapyInfluenza TreatmentPediatric Antiviral PharmacologyPediatric Antiviral TherapyPediatric Viral Infections
Immunosuppressed patients receiving oseltamivir for 2009 novel H1N1 influenza A infection may develop drug resistance, leading to treatment failure. Intravenous zanamivir was administered on a compassionate-use basis to a profoundly immunosuppressed pediatric patient with severe oseltamivir-resistant novel H1N1 pneumonia. The regimen was well tolerated and was associated with a decrease in viral burden.
8